These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15089787)

  • 1. A double-blind study comparing 0.5% and 1% tropicamide for annual retinal screening in diabetic adolescents.
    Hassler-Hurst J; Wadham C; Rayman G
    Diabet Med; 2004 May; 21(5):434-9. PubMed ID: 15089787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single dose of 1% tropicamide and 10% phenylephrine for pupil dilation.
    Ratanapakorn T; Yospaiboon Y; Chaisrisawadsuk N
    J Med Assoc Thai; 2006 Nov; 89(11):1934-9. PubMed ID: 17205877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combination solution for routine pupillary dilation.
    Krumholz DM; Portello JK; Rosenfield M; Rosenbaum JD
    Optometry; 2006 Jul; 77(7):350-3. PubMed ID: 16814239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does prior instillation of a topical anaesthetic alter the pupillary mydriasis produced by tropicamide (0.5%)?
    Haddad DE; Rosenfield M; Portello JK; Krumholz DM
    Ophthalmic Physiol Opt; 2007 May; 27(3):311-4. PubMed ID: 17470245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of efficacy and tolerance between 1% hydroxyamphetamine plus 0.25% tropicamide (Paremyd) and 0.5% tropicamide combined with 2.5% phenylephrine.
    Zeise MM; McDougall BW; Bartlett JD; Corliss D; Mitten L
    J Am Optom Assoc; 1996 Nov; 67(11):681-9. PubMed ID: 8979662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between obtained mydriasis in type 2 diabetics and non-diabetic patients.
    Coblentz J; Motta MM; Fernandes BF; Burnier MN; Vianna RN
    Curr Eye Res; 2009 Nov; 34(11):925-7. PubMed ID: 19958108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of mydriatic efficacy of spray application and drop instillation of tropicamide 1%.
    Akman A; Aydin P
    Eye (Lond); 1999 Oct; 13 ( Pt 5)():653-5. PubMed ID: 10696320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mydriatic and cardiovascular effects of phenylephrine 2.5% versus phenylephrine 10%, both associated with tropicamide 1%.
    Motta MM; Coblentz J; Fernandes BF; Burnier MN
    Ophthalmic Res; 2009; 42(2):87-9. PubMed ID: 19478547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pupil dilation using phenylephrine alone or in combination with tropicamide.
    Eyeson-Annan ML; Hirst LW; Battistutta D; Green A
    Ophthalmology; 1998 Apr; 105(4):726-32. PubMed ID: 9544648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mist delivery of eye medication to the anterior segment.
    Collins JF; Dartt DA; Dana R
    Am J Ophthalmol; 2007 Jul; 144(1):137-9. PubMed ID: 17601439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimizing risk of adverse reactions to mydriatic agents in binocular indirect ophthalmoscopy.
    Levine L
    J Am Optom Assoc; 1985 Jul; 56(7):542-8. PubMed ID: 4020007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effectiveness of mydriasis by two instillation methods of combined 0.75% tropicamide and 2.5% phenylephrine eye drop in preterm infants.
    Phamonvaechavan P; Chutasmit K; Damrongrak P; Koukiatkul S; Wongkiatkajorn T; Ngerncham S
    J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S1-7. PubMed ID: 22696845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mydriatic effect of multiple doses of tropicamide.
    Siderov J; Nurse S
    Optom Vis Sci; 2005 Nov; 82(11):955-8. PubMed ID: 16317370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of potentiating effect of a drop of lignocaine on tropicamide-induced mydriasis.
    Ghose S; Garodia VK; Sachdev MS; Kumar H; Biswas NR; Pandey RM
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1581-5. PubMed ID: 11381064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tropicamide test in patients with dementia of Alzheimer type and frontotemporal dementia.
    Robles A; Touriño R; Gude F; Noya M
    Funct Neurol; 1999; 14(4):203-7. PubMed ID: 10713893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pupillary dilation and funduscopy with 1.0% hydroxyamphetamine plus 0.25% tropicamide (Paremyd) versus tropicamide (0.5 or 1.0%) as a function of iris and skin pigmentation, and age.
    Cooper J; Feldman JM; Jaanus SD; Appleman W; Appel S; Horn D
    J Am Optom Assoc; 1996 Nov; 67(11):669-75. PubMed ID: 8979660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of 5% phenylephrine and 0.5% tropicamide eyedrops for pupil dilation in neonates is twice as effective as 0.5% tropicamide eyedrops alone.
    Lux AL; Degoumois A; Barjol A; Mouriaux F; Denion E
    Acta Ophthalmol; 2017 Mar; 95(2):165-169. PubMed ID: 27519933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tropicamide (1%): an effective cycloplegic agent for myopic children.
    Manny RE; Hussein M; Scheiman M; Kurtz D; Niemann K; Zinzer K;
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1728-35. PubMed ID: 11431435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mydriasis with different preparations of topically administered lidocaine hydrochloride.
    Claesson M; Johansson M; Behndig A
    J Cataract Refract Surg; 2009 Feb; 35(2):277-81. PubMed ID: 19185243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective pupil dilatation with a mixture of 0.75% tropicamide and 2.5% phenylephrine: A randomized controlled trial.
    Trinavarat A; Pituksung A
    Indian J Ophthalmol; 2009; 57(5):351-4. PubMed ID: 19700872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.